Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ASPTSE:CTXCVE:FLWRCVE:KHRN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASPAmerican Strategic Income Portfolio$6,304.00$0.00▼$0.00N/AN/AN/A8,370 shsCTXCrescita TherapeuticsC$0.54+5.9%C$0.56C$0.41▼C$0.69C$9.94M1.6914,678 shs3,500 shsFLWRFlowrC$0.03C$0.02C$0.02▼C$0.11C$10.66MN/A302,866 shs29,006 shsKHRNKhiron Life SciencesC$0.04C$0.04C$0.04▼C$0.21C$9.30M2.64256,268 shs24,000 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASPAmerican Strategic Income Portfolio0.00%0.00%0.00%0.00%0.00%CTXCrescita Therapeutics0.00%+5.88%-5.26%-3.57%+14.89%FLWRFlowr0.00%0.00%0.00%0.00%0.00%KHRNKhiron Life Sciences0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASPAmerican Strategic Income PortfolioN/AN/AN/AN/AN/AN/AN/AN/ACTXCrescita TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AFLWRFlowrN/AN/AN/AN/AN/AN/AN/AN/AKHRNKhiron Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASPAmerican Strategic Income Portfolio 0.00N/AN/AN/ACTXCrescita Therapeutics 0.00N/AN/AN/AFLWRFlowr 0.00N/AN/AN/AKHRNKhiron Life Sciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASPAmerican Strategic Income PortfolioN/AN/AN/AN/AN/AN/ACTXCrescita TherapeuticsC$16.62M0.60C$0.45 per share1.20C$0.83 per share0.65FLWRFlowrC$12.92M0.83C$0.00 per share8.33C$0.00 per share-25.00KHRNKhiron Life SciencesC$18.08M0.51C$0.01 per share6.67C$0.20 per share0.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASPAmerican Strategic Income PortfolioN/AN/A0.00N/AN/AN/AN/AN/AN/ACTXCrescita Therapeutics-C$2.61M-C$0.15N/A∞N/A-15.73%-15.60%-8.26%N/AFLWRFlowrN/A-C$0.21N/A∞N/AN/AN/AN/AN/AKHRNKhiron Life Sciences-C$46.80M-C$0.20N/A∞N/A-258.92%-68.62%-20.79%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASPAmerican Strategic Income PortfolioN/AN/AN/AN/AN/ACTXCrescita TherapeuticsN/AN/AN/AN/AN/AFLWRFlowrN/AN/AN/AN/AN/AKHRNKhiron Life SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASPAmerican Strategic Income PortfolioN/AN/AN/ACTXCrescita Therapeutics5.772.702.29FLWRFlowr71.271.130.15KHRNKhiron Life Sciences6.683.080.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASPAmerican Strategic Income PortfolioN/ACTXCrescita TherapeuticsN/AFLWRFlowrN/AKHRNKhiron Life Sciences0.22%Insider OwnershipCompanyInsider OwnershipASPAmerican Strategic Income PortfolioN/ACTXCrescita Therapeutics10.87%FLWRFlowrN/AKHRNKhiron Life Sciences4.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASPAmerican Strategic Income PortfolioN/AN/AN/ANot OptionableCTXCrescita Therapeutics6218.41 millionN/ANot OptionableFLWRFlowr186426.47 millionN/ANot OptionableKHRNKhiron Life SciencesN/A232.41 millionN/ANot OptionableASP, FLWR, CTX, and KHRN HeadlinesRecent News About These CompaniesPharmadrug Stock (OTC:LMLLF), Quotes and News SummaryMay 23, 2024 | benzinga.comFocus: Colombia's cannabis industry in crisis over regulatory, political hurdlesDecember 21, 2023 | msn.comGlobal Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealNovember 17, 2023 | benzinga.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessNovember 16, 2023 | finance.yahoo.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)May 4, 2023 | theglobeandmail.comKhiron Life Sciences Issues An UpdateApril 26, 2023 | technical420.comClosing Bell: Khiron Life Sciences Corp down on Tuesday (KHRN)April 26, 2023 | theglobeandmail.comCannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & MoreApril 25, 2023 | msn.comMedical First: Germany Strengthens Reimbursement of Medical CannabisApril 25, 2023 | finance.yahoo.comClosing Bell: Khiron Life Sciences Corp WT flat on Friday (KHRN-WT)April 22, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp up on Thursday (KHRN)April 21, 2023 | theglobeandmail.comKhiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS SubsidiaryApril 21, 2023 | msn.comClosing Bell: Khiron Life Sciences Corp WT flat on Tuesday (KHRN-WT)April 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp flat on Friday (KHRN)April 15, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Wednesday (KHRN)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Thursday (KHRN-WT)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Wednesday (KHRN-WT)April 7, 2023 | theglobeandmail.comKhiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment OptionApril 4, 2023 | finance.yahoo.comMedia Sentiment Over TimeASP, FLWR, CTX, and KHRN Company DescriptionsAmerican Strategic Income Portfolio NYSE:ASPAmerican Strategic Income Portfolio Inc. (ASP) invests in mortgage-related assets that directly or indirectly represent a participation in or are secured by and payable from mortgage loans. The Fund may also invest in the United States Government securities, corporate debt securities, preferred stock issued by real estate investment trusts, and mortgage servicing rights. In addition, the Fund may borrow using reverse repurchase agreements and credit facilities. The Fund's primary objective is to achieve high levels of current income. Its secondary objective is to seek capital appreciation. The Barclays Capital Mutual Fund Government/Mortgage Index, ASP's benchmark, consists of all the United States Government agency and Treasury securities and agency mortgage-backed securities. The Fund's investment advisor is U.S. Bancorp Asset Management, Inc. ASP's sub-advisors include Nuveen Asset Management, LLC and Nuveen Fund Advisors, Inc.Crescita Therapeutics TSE:CTXC$0.54 +0.03 (+5.88%) As of 05/22/2025 09:31 AM EasternCrescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.Flowr CVE:FLWRC$0.02 0.00 (0.00%) As of 10/17/2022The Flowr Corporation cultivates, produces, and sells cannabis in Canada. The company offers dried flowers and pre-rolls. It also has operations in Canada, Portugal, and the European Union. The company was incorporated in 2016 and is headquartered in Toronto, Canada.Khiron Life Sciences CVE:KHRNC$0.04 0.00 (0.00%) As of 05/5/2023Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1 Cathie Wood Just Bought a New Stake in Taiwan Semiconductor Stock Super Micro Computer Stock Clears New Path Higher on Saudi Orders Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith? Why Carnival Could Be the Ultimate Non-Tech Growth Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
